Loading, please wait...
Due to concerns about the novel coronavirus, and consistent with ongoing efforts to reduce spread of the virus, attendance for these CE sessions will be WEBINAR ONLY. Please see instructions below for registration.
PLEASE FOLLOW THE STEP-BY-STEP INSTRUCTIONS BELOW – DO NOT SKIP STEPS!
STEP 1: SIGN INTO YOUR ACCOUNT AND REGISTER FOR EACH SESSION YOU WOULD LIKE TO ATTEND
** If you do not register for the CE at this link, you will not be able to access the evaluations to earn credit
** EVERYONE must register BEFORE the session date. NO NEW REGISTRATIONS WILL BE ADDED AFTER THE PROGRAM DATE
** You will receive an email confirming your registration at the email address provided – if you do not receive a confirmation email, try to register again
**New sessions may be added throughout the month, so do not assume you are automatically registered for all sessions.
STEP 2: AFTER SUCCESSFULLY REGISTERING ON THIS SITE - AT THE TIME OF THE PROGRAM, EXPAND THE MODULE AT THE BOTTOM OF THIS PAGE AND CLICK THE WEBEX LINK.
The Link will not be emailed to you. It can only be found on this page.
** submit your contact information
STEP 3: Collect the presenter code for each of the CEs that you attend
** EVERYONE will need the presenter codes to access evaluations and earn CE credit
STEP 4: You will receive an automated email to log in and complete evaluations
** Evaluations must be completed within 60 days of the CE session
** You will need the presenter codes to access each evaluation
** Evaluations MUST be completed within 60 days of the program date to earn CE credit!
Date: Jan 1, 2021 01:00 AM - Jan 31, 2021 11:55 PM
CE Hours
5.00
CE Units
0.500
Registration closes on Jan 31, 2021 11:55 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
REGISTRATION NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.
If paying by check please mail to the address below: 301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
|
|
|
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**
|
Co-Sponsor(s)
UNC Health System
Support/Credits
Cancelations: Cancelations must be received in writing/email to the Office of Continuing Education at least 48 hours prior to start date to receive a full refund. No refunds will be given within 48 hours of the start date.
IMPORTANT: UNC HEALTH SYSTEM EMPLOYEES AND UNC ESHELMAN SCHOOL OF PHARMACY STUDENTS ONLY
UNC Health System Employees and ESOP Students are able to attend this Resident Series at no charge to them. If you are a Health System Employee or Student please follow the steps below. This only applies to this series.
- UNC Health System Employees and UNC ESOP Students should register using your UNC email address. UNC Employees - please select your employment location during the registration process. UNC Students - please respond "Yes" to the "Are you a UNC Student" question.
- Select the “Check” payment method on the registration page. Your employment will be verified prior to credit being uploaded
This session will provide a high-level overview to the ever changing payer landscape and how it is impacting our patients.
Meeting: 160 032 5747
Password: UNCPharm1
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Define Vertical Integration
- Describe the implications of vertical integrations within healthcare
- Describe the impact on provider administered and specialty retail medications
- Identify strategies health-system pharmacy departments can employ to combat vertical integration
Speaker(s)/Author(s)
|
Conor Myers, PharmD
|
Activity Number
0046-9999-21-019-L04-P
Date:
01/07/21
Time:
05:00 PM - 05:30 PM
CE Hours
0.50
Location
Online
Pharmacist and pharmacy technicians will better understand artificial intelligence, recognize it in every day practice, and identify how it may be used in the future to evolve the profession.
Meeting: 160 032 5747
PassworW: UNCPharm1
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Describe and understand artificial intelligence and machine learning
- Identify how artificial intelligence is integrated into healthcare and pharmacy
- Outline how artificial intelligence can impact the future of pharmacy
Speaker(s)/Author(s)
|
Autumn Petersen, PharmD, MPH
|
Activity Number
0046-9999-21-028-L04-P/T
Date:
01/07/21
Time:
05:30 PM - 06:00 PM
CE Hours
0.50
Location
Online
Meeting: 160 815 2210
Password: UNCPharm1
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Describe the pathophysiology, clinical presentation, and diagnosis of acquired thrombotic thrombocytopenia purpura (TTP)
- Review current guideline-recommended management of acquired TTP.
- Outline the literature for the use of caplacizumab in acquired TTP, including its cost-effectiveness.
- Develop evidence-based recommendations regarding the role of caplacizumab in acquired TTP.
Activity Number
0046-9999-21-027-L01-P
Date:
01/14/21
Time:
05:00 PM - 06:00 PM
CE Hours
1.00
Multiple myeloma (MM) is a rare plasma cell malignancy. In the setting of relapsed and refractory MM there can be several factors that influence treatment decisions. This presentation intends to guide and inform the audience on new available regimens for the treatment of this patient population and how to utilize this regimens in real practice.
Meeting: 160 892 6919
Password: UNCPharm1
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Outline the current treatment approach in relapse and refractory Multiple Myeloma (MM)
- Describe the pharmacology and management of new and emerging treatments in MM
- Discuss strategies to operationalize new treatments in MM
Speaker(s)/Author(s)
|
Ashley Chen, PharmD
|
Activity Number
0046-9999-21-025-L01-P
Date:
01/21/21
Time:
05:00 PM - 06:00 PM
CE Hours
1.00
This program will be held from 1p-2p, then repeated from 2p-3p.
Objectives
- Recall the pathophysiology and epidemiology of pediatric sickle cell disease
- Discuss the management and prevention of complications of pediatric sickle cell disease
- Summarize treatment recommendations for sickle cell pain management in the pediatric pollution
- Examine new and emerging treatment for vaso-occlusive crises in the pediatric population
Speaker(s)/Author(s)
|
Sheniece Carpenter, PharmD, MSCR
|
Activity Number
0046-9999-21-030-L01-P
Date:
01/27/21
Time:
01:00 PM - 03:00 PM
CE Hours
1.00
Fee
$10.00
This CE presentation is largely focused on the new disease modifying therapies in Multiple Sclerosis. This topic will introduce the audience to these new therapies, the clinical data resulting in their FDA approval, important side effects and monitoring parameters, and finally discuss potential places in therapy.
Meeting: 160 070 9679
Password: UNCPharm1
Objectives
- Review the pathophysiology, phenotypes, and presentation of multiple sclerosis.
- Discuss multiple sclerosis trial design and important clinical outcomes.
- Outline primary literature which lead to FDA approval of cladribine, siponimod, ozanimod, and ofatumumab.
- Describe safety and efficacy of new disease modifying therapy and determine appropriate place in multiple sclerosis therapy.
Speaker(s)/Author(s)
|
Allison Behrens, PharmD
|
Activity Number
0046-9999-21-029-L01-P/T
Date:
01/28/21
Time:
05:00 PM - 06:00 PM
CE Hours
1.00
Fee
$10.00